Matthew Brown

Mr. Matthew Brown

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2014 in Biological Conservation
Verified
Journal Article
Open access
TTTimothy H. Tear
Timothy H. Tear
BSBradford N. Stratton
Bradford N. Stratton
EGEdward T. Game
Edward T. Game
MBMatthew Brown
Matthew Brown
CAColin D. Apse
Colin D. Apse
RSRebecca R. Shirer
Rebecca R. Shirer
Environmental conservation activities must continue to become more efficient and effective, especially in Africa where development and population growth pressures continue to escalate. Recently, prioritization of conservation resources has focused on explicitly incorporating the economic costs of conservation along with better defining the outcomes of these expenditures. We demonstrate how new global and continental data that spans social, economic, and ecological sectors creates an opportunity to incorporate return-on-investment (ROI) principles into conservation priority setting for Africa. We suggest that combining conservation priorities that factor in biodiversity value, habitat quality, and conservation management investments across terrestrial, freshwater, and coastal marine environments provides a new lens for setting global conservation priorities. Using this approach we identified seven regions capturing interior and coastal resources that also have high ROI values that support further investment. We illustrate how spatially explicit, yet flexible ROI analysis can help to better address uncertainty, risk, and opportunities for conservation, while making values that guide prioritization more transparent. In one case the results of this prioritization process were used to support new conservation investments. Acknowledging a clear research need to improve cost information, we propose that adopting a flexible ROI framework to set conservation priorities in Africa has multiple potential benefits

7 August 2023 in BMJ Public Health
Verified
Journal Article
Open access
PDF file
MBMatthew Brown
Matthew Brown
JGJohn Gerrard
John Gerrard
LMLynne McKinlay
Lynne McKinlay
JMJohn Marquess
John Marquess
TSTeneika Sparrow
Teneika Sparrow
RARoss Andrews
Ross Andrews
Objective In a highly vaccinated Australian population, we aimed to compare ongoing symptoms and functional impairment 12 weeks after PCR-confirmed COVID-19 infection with PCR-confirmed influenza infection. Methods and analysis The study commenced on a positive PCR test for either COVID-19 or influenza in June 2022 during concurrent waves of both viruses. Participants were followed up 12 weeks later in September 2022 and self-reported ongoing symptoms and functional impairment. We conducted a multivariate logistic regression analysis, controlling for age, sex, First Nations status, vaccination status and socioeconomic profile. Results There were 2195 and 951 participants in the COVID-19 and influenza-positive cohorts, respectively. After controlling for potential predictor variables, we found no evidence to suggest that adults with COVID-19 were more likely to have ongoing symptoms (21.4% vs 23.0%, aOR 1.18; 95% CI 0.92 to 1.50) or moderate-to-severe functional impairment (4.1% vs 4.4%, OR 0.81; 95% CI 0.55 to 1.20) at 12 weeks after their diagnosis than adults who had influenza. Conclusions In a highly vaccinated population exposed to the SARS-CoV-2 Omicron variant, long COVID may manifest as a postviral syndrome of no greater severity than seasonal influenza but differing in terms of the volume of people affected and the potential impact on health systems. This study underscores the importance of long COVID research featuring an appropriate comparator group. Trial registration number ACTRN12623000041651.

28 January 2014 in Environmental Conservation
Verified
Journal Article
Closed access
PDF file
EGEvan H. Girvetz
Evan H. Girvetz
EGElizabeth Gray
Elizabeth Gray
TTTimothy H. Tear
Timothy H. Tear
MBMatthew Brown
Matthew Brown
SUMMARY: In the face of an already changing climate, conservation practitioners and local communities face the major challenge of how to plan for a future climate. In data-sparse areas of the world, where action is often most needed, the daunting scope of the problem can lead to inaction. This paper shows that climate adaptation planning can be accomplished successfully with publicly and globally available data by linking science and stakeholders through a facilitated process. Working with local stakeholders in the western Tanzanian Greater Mahale and Greater Gombe Ecosystems, future climate projections produced using Climate Wizard and analyses of literature provided an understanding of the climate vulnerabilities of local ecosystems and human livelihoods. Facilitated workshops enabled local stakeholders to use this information to develop conceptual models and hypotheses of change for these systems, and to identify possible modifications to conservation plans. Here, climate change planning required the modification of most current conservation strategies, developing some new strategies and abandoning others. The paper indicates that climate adaptation planning is achievable even in data-sparse rural and developing areas, but requires appropriate scientific analyses, engaged stakeholders and a facilitated process.

23 May 2024 in The Lancet
Verified
Journal Article
Closed access
MBMatthew Brown
Matthew Brown
JGJohn Gerrard
John Gerrard
CMCatherine McDougall
Catherine McDougall
JMJulie MacPhail
Julie MacPhail
OWOlivia Williams
Olivia Williams

28 September 2025 in Medical Journal of Australia
Verified
Journal Article
Open access
MBMatthew Brown
Matthew Brown
AHAlan W Hampson
Alan W Hampson
JGJohn Gerrard
John Gerrard

17 April 2023 in medRxiv
Verified
Preprint
Open access
PDF file
MBMatthew Brown
Matthew Brown
JGJo Gerrard
Jo Gerrard
LMLynne McKinlay
Lynne McKinlay
JMJohn Marquess
John Marquess
TSTeneika Sparrow
Teneika Sparrow
RARoss Andrews
Ross Andrews
Objective: In a highly vaccinated Australian population we aimed to compare ongoing symptoms and functional impairment 12 weeks after PCR-confirmed COVID-19 infection with PCR-confirmed influenza infection. Methods and Analysis: The study commenced upon a positive PCR test for either COVID-19 or influenza in June 2022 during concurrent waves of both viruses. Participants were followed up 12 weeks later in September 2022 and self-reported ongoing symptoms and functional impairment. We conducted a multivariate logistic regression analysis, controlling for age, sex, First Nations status, vaccination status, and socio-economic profile. Results: There were 2 195 and 951 participants in the COVID-19 and influenza-positive cohorts respectively. After controlling for potential predictor variables, we found no evidence to suggest adults with COVID-19 were more likely to have ongoing symptoms (21.4% vs 23.0%, aOR 1.18; 95% CI 0.92-1.50) or moderate to severe functional impairment (4.1% vs 4.4%, OR 0.81; 95% CI 0.55-1.20) at 12 weeks after their diagnosis than adults who had influenza. Conclusions: In a highly vaccinated population exposed to the SARS-CoV-2 omicron variant, long COVID may manifest as a post-viral syndrome of no greater severity than seasonal influenza but differing in terms of the volume of people affected and the potential impact on health systems. This study underscores the importance of long COVID research featuring an appropriate comparator group. What is already known on this subject?: Post-acute infection syndromes are associated with a range of illnesses, including COVID-19 and influenza. “Long COVID” may pose a risk to health systems. What are the new findings?: In a highly vaccinated population whose primary exposure has been to the Omicron variant, the rates of ongoing symptoms and moderate to severe functional impairment at 12 weeks after COVID-19 are no different to influenza. How might these results change the focus of research or clinical practice?: The public health impact arising from long COVID may not stem from severity, but from volume. We do not dismiss the validity of long COVID but recommend an appropriate comparator group when researching this condition.